...
首页> 外文期刊>Biomedicine & pharmacotherapy =: Biomedecine & pharmacotherapie >The mechanisms of somatostatin induced enhanced chemosensitivity of gallbladder cancer cell line to doxorubicin: cell cycle modulation plus target enzyme up-regulation.
【24h】

The mechanisms of somatostatin induced enhanced chemosensitivity of gallbladder cancer cell line to doxorubicin: cell cycle modulation plus target enzyme up-regulation.

机译:生长抑素诱导胆囊癌细胞系对阿霉素的化学敏感性增强的机制:细胞周期调节加靶酶上调。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Gallbladder carcinoma is known to be an aggressive malignancy and nonsensitive to routine chemotherapy. Its prognosis is quite poor. We have illustrated that somatostatin (SST) can enhance chemosensitivity of gallbladder cancer to Doxorubicin (DOX) in our precious studies. Here, we explored the possible mechanisms by which SST used to enhance the cytotoxicity of DOX on gallbladder carcinoma cell line. METHODS: Human gallbladder cancer cells line (GBC-SD cell line) were divided into four groups: control group, SST group, DOX group, SST+DOX co-treated-group. Cell cycle was detected by flow cytometry (FCM). Cell apoptosis index was detected by using Annexin V/Propidium Iodide Binding on FCM. The expressions of certain key cell cycle-related factors, including retinoblastoma protein (Rb) and E2F-1 protein were investigated by western blotting. ICBP90 protein, which could be a new downstream effector of E2F-1, was also detected by western blotting. The expression of Topo IIalpha protein, target enzyme of DOX, was assessed in synchronized GBC-SD cells by western blotting. RESULTS: After 24h treatment with SST alone, cell cycle was arrested at S phase in GBC-SD cells line, followed by indistinctive increment of apoptosis index. After 24h treatment with SST and DOX, apoptosis index significantly increased than that of DOX alone (P<0.05). Compared with control group, the expressions of Rb and E2F-1 protein were significantly up-regulated at 24h after treatment with SST. Similarly, the expressions of ICBP90 and Topo IIalpha protein were also enhanced at 24h after treatment with SST. CONCLUSION: These results suggested that SST could induce cell cycle block in S phase in GBC-SD cells line, the most sensitive phase of the cell cycle for DOX, through up-regulating Rb, E2F-1 and ICBP90 protein expression. Furthermore, ICBP90 induced the enhanced expression of Topo IIalpha protein which is the target enzyme of DOX and enhanced its cytotoxic effect on GBC-SD cells. We concluded that the mechanisms of SST enhanced chemosensitivity of GBC-SD cell line to DOX might be cell cycle arrest plus up-regulated target enzyme.
机译:背景:胆囊癌是一种恶性肿瘤,对常规化疗不敏感。其预后很差。在我们的宝贵研究中,我们已经证明生长抑素(SST)可以增强胆囊癌对阿霉素(DOX)的化学敏感性。在这里,我们探讨了SST用来增强DOX对胆囊癌细胞系细胞毒性的可能机制。方法:将人胆囊癌细胞系(GBC-SD细胞系)分为四组:对照组,SST组,DOX组,SST + DOX联合治疗组。通过流式细胞术(FCM)检测细胞周期。通过在FCM上使用膜联蛋白V /碘化丙啶结合来检测细胞凋亡指数。通过蛋白质印迹研究了某些关键的细胞周期相关因子的表达,包括视网膜母细胞瘤蛋白(Rb)和E2F-1蛋白。还通过蛋白质印迹检测到了ICBP90蛋白,它可能是E2F-1的新下游效应子。通过蛋白质印迹法评估了同步化的GBC-SD细胞中DOX靶标酶Topo IIalpha蛋白的表达。结果:单独用SST处理24h后,GBC-SD细胞系的细胞周期停在S期,随后凋亡指数的增加不明显。 SST和DOX处理24h后,细胞凋亡指数明显高于单独的DOX(P <0.05)。与对照组相比,SST处理24h后Rb和E2F-1蛋白的表达明显上调。类似地,在用SST处理后24小时,ICBP90和TopoIIα蛋白的表达也被增强。结论:这些结果表明,SST可以通过上调Rb,E2F-1和ICBP90蛋白表达来诱导GBC-SD细胞系S期中的细胞周期阻滞,GBC-SD细胞系是DOX细胞周期最敏感的阶段。此外,ICBP90诱导了DOX的靶标酶Topo IIalpha蛋白的表达增强,并增强了其对GBC-SD细胞的细胞毒性作用。我们得出结论,SST增强GBC-SD细胞系对DOX的化学敏感性的机制可能是细胞周期阻滞加上调的靶酶。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号